Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivanza Biosciences

BSE: 530057|ISIN: INE984E01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 04, 16:00
15.20
0
VOLUME 1
Vivanza Biosciences is not listed on NSE
Announcements on Vivanza Bio

12th-Nov-2019 15:34Source: BSE

Vivanza Biosciences- Results- Financial Results For September 30, 2019

Results- Financial Results for September 30, 2019

4th-Nov-2019 18:13Source: BSE

Vivanza Biosciences- Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended 30Th September, 2019.

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the...

25th-Oct-2019 14:45Source: BSE

Vivanza Biosciences- Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''The Regulations'') For The Half Year Ended 30Th September, 2019

Pursuant to Regulation 40(10) of the Regulations we are submitting herewith the Compliance Certificate received from a Practicing Company Secretary, for Compliances by the Company under Regulation 40(...

23rd-Oct-2019 17:51Source: BSE

Vivanza Biosciences- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parth H Parikh

23rd-Oct-2019 17:48Source: BSE

Vivanza Biosciences- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant A Parikh

17th-Oct-2019 19:30Source: BSE

Vivanza Biosciences- Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parth ...

17th-Oct-2019 19:06Source: BSE

Vivanza Biosciences- Announcement under Regulation 30 (LODR)-Acquisition

Disclosure of Inter-se Transfer of Shares between the Promoter and his immediate relative in accordance with Reg. 10(5) of SEBI SAST Regulations, 2011.

10th-Oct-2019 17:08Source: BSE

Vivanza Biosciences- Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor compl...

4th-Oct-2019 12:37Source: BSE

Vivanza Biosciences- Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Vivanza Biosciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

2nd-Oct-2019 13:40Source: BSE

Vivanza Biosciences- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Disclosure under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 alongwith Scrutinizer''s Report for 37th Annual General Meeting (AGM) held on Monday, ...

1 2 3 4 5 Next >>
Quick Links for Vivanza Biosciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.